Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
PHCTF-G03-02803
Study information
Scientific title
Acronym
TIPS
Study hypothesis
The number of hospital days for eligible palliative patients would be decreased by at least 30% for those patients who receive telehomecare versus those who receive standard care in the community
Ethics approval
Approved by Mount Sinai Research Ethics Board, 8th September 2004, reference number: 04-0187-E
Study design
Randomized controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Not specified
Trial type
Treatment
Patient information sheet
Condition
Palliative oncology
Intervention
Intervention: telehomecare equipment including videophones, blood pressure measurement devices, pulse oximeters, and stethoscopes placed in patient homes, operated remotely by registered nurses, physicians, and case managers. Face to face visits also provided.
Control: standard homecare.
Intervention type
Other
Phase
Not Specified
Drug names
Primary outcome measure
Utilization of acute care services
Secondary outcome measures
1. Quality of life (patient and family caregiver)
2. Pain and symptom management (patient)
3. General health status (family caregiver)
4. Satisfaction (patient, family caregiver, health care professional)
Overall trial start date
18/10/2004
Overall trial end date
30/04/2006
Reason abandoned (if study stopped)
Eligibility
Participant inclusion criteria
1. Newly referred to palliative care
2. Cancer diagnosis
3. Over 18 years of age
4. English speaking
5. Someone in the home able to operate the telehomecare equipment
6. Three pronged outlet in home
7. Digital Subscriber Line provision possible
Participant type
Patient
Age group
Adult
Gender
Both
Target number of participants
300
Participant exclusion criteria
Life expectancy <2 weeks upon referral as evidenced by a palliative performance scale (PPS) score of 20% or less
Recruitment start date
18/10/2004
Recruitment end date
30/04/2006
Locations
Countries of recruitment
Canada
Trial participating centre
600 University Avenue
Toronto
M5G 1X5
Canada
Sponsor information
Organisation
Primary Health Care Transition Fund (Canada)
Sponsor details
5700 Yonge Street
Third Floor
North York
M2M 4K5
Canada
+1 416 327 7543
Jeffrey.Kwok@moh.gov.on.ca
Sponsor type
Government
Website
http://www.hc-sc.gc.ca/hcs-sss/prim/phctf-fassp/index_e.html
Funders
Funder type
Government
Funder name
Primary Health Care Transition Fund PHCTF-G03-02803
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Basic results (scientific)
Publication list